RSS   Newsletter   Contact   Advertise with us
Post Online Media

James Barrett resigns from Supernus board

SupernusSupernus Pharmaceuticals, a specialty pharmaceutical company, announced that M. James Barrett has resigned from its board of directors.
Article continues below

READ MORE Intel chairman Craig Barrett to retire in May

Dr. Barrett, currently Partner Emeritus at New Enterprise Associates (NEA), a venture capital firm that focuses on the life sciences and information technology industries, had served as the Chairman of the Board of Directors since 2005 when NEA was the lead investor in Supernus.

Dr. Barrett's resignation is consistent with NEA's exit from Supernus late last year, and with his need to With the announcement of Dr. Barrett's departure, the Board unanimously elected Charles W. Newhall, III, a current independent director, as Chairman.

Mr. Newhall has served as a member of our Board since 2005, and currently serves as Chair of the Governance and Nominating Committee.

Mr. Newhall started several healthcare information technology companies, including PatientKeeper, TargetRx, and LifeMetrix.

He currently serves on the Boards of Interfusion, Neuropace, and Vitae Pharmaceuticals, and as Chairman Emeritus of the Industry Advisory Board for Greenspring Associates. In 1977, Mr. Newhall co-founded NEA from which he retired in 2012.

Prior to that, he was a Vice President of T. Rowe Price.

Mr. Newhall is a decorated Vietnam veteran and has an MBA from the Harvard Business School.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy